跳至主要内容
临床试验/CTRI/2026/04/109439
CTRI/2026/04/109439尚未招募Phase 3 4

A RANDOMISED CONTROLLED CLINICAL TRIAL ON THE EFFECT OF SPHATIK DRAVA BASTI IN THE MANAGEMENT OF ARSHA WSR TO SECOND DEGREE INTERNAL HAEMORRHOIDS.

Dr. Mohini Kedar1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2026年5月19日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
74
试验地点
1

研究概览

简要总结

The Present Study is a PG Thesis Topic

By PG Scholar - DR Mohini Mukund Kedar and Guide Name - DR D.D. Chavan                                                Title : RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF SPHATIKA DRAVA BASTI IN MANAGEMENT OF ARSHA W.S.R TO SECOND DEGREE HAEMORRHOIDS.                                                                                                                                                                                                  According to inclusion and exclusion criteria

Group A 37 patients and Group B 37 patients will be selected

Group A ( intervention ) will be given shatika drava basti 60ml for 3 days.

Group B ( control/ comparative ) will be given inj. polidocanol 1-3ml per pile mass.

Total Duration of stud y is 1 year 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients aged 18-60 years.
  • diagnosed with second degree haemorrhoids.

排除标准

  • inflamed, strangulated or thrombosed hemorrhoids.
  • associated painful conditions like fistula, abscess, malignancy etc.
  • severe systemic illness eg diabetes, cardiac conditions etc 4)patients eith hb less than 10 gm percent.
  • pregnant and lactating women.

研究者

发起方
Dr. Mohini Kedar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Mohini Mukund Kedar

Dr. G. D Pol, Foundation, YMT Ayurvedic Medical College And Hospital

研究点 (1)

Loading locations...

相似试验